Hear about interesting companies that have gone from private to public
Behind each journey there’s a sense of ambition we can relate to at Stake.
Episode 1 | How to Bring Life-saving Aussie Tech to a Global Market
Episode 2 | Breaking the Bank(s)
In Going Public with Scott Kirkland, co-founder & CEO of EMVision (ASX: EMV), unpacks how listing the compnay has helped developed portable electromagnetic microwave imaging solutions to reduce the burden of strokes.
In Going Public with Joseph Healy, co-founder & CEO of Judo Bank (ASX: JDO), shares the IPO journey of the challenger bank focused on SMEs that have been left behind on service by the established institutions.
Episode 3 | Choosing the Market for Success
Episode 4 | Why this Multi-Billion-Dollar Aussie Company Listed on the ASX
In Going Public with Oleg Vornik, CEO and Managing Director of DroneShield (ASX: DRO), discuss the decision to list the American company, providing counter-drone protection technologies, on the ASX.
In Going Public with Richard White, founder and CEO of WiseTech Global (ASX: WTC), unpacks the Australian tech success story offering leading logistics management software around the globe.
Episode 5 | Managing Expectations in a Tough Macroeconomic Environment
Episode 6 | Breaking Ground in Cancer Research
In Going Public with Tim Fung, co-founder and CEO of Airtasker (ASX: ART), shares the IPO journey of the Aussie-bred online marketplace allows 6 million users worldwide to outsource a variety of everyday tasks.
In Going Public with Dr Alan Taylor, Executive Chair of Clarity Pharmaceuticals (ASX: CU6), shares the story of Australia's largest pure biotech IPO in the history of the ASX.
Episode 7 | Technological Innovation, Global Growth & Resilience
Episode 8 |Advancements in Sports Safety Tech
In Going Public with Eliran Glazer, CFO of Monday.com (NASDAQ: MNDY), shares how the dynamic project management platform listed on the NASDAQ and dives into the importance of long term planning.
In Going Public with Mike Vegar, Co-founder & Managing Director of HITIQ (ASX: HIQ), shares the IPO journney that's helped develop the world’s first end-to-end concussion management platform with products that support identifying, monitoring & ongoing management of sport-related head impacts.
Episode 9 | Fighting Antibiotic Resistance
Episode 10 | Transforming MMA Training
In Going Public with James Graham, Mark speaks with one of the ASX’s youngest CEOs, at the helm of a growing medical technology firm taking on the global health crisis of antibiotic resistance.
In Going Public with Nick Landon, Train Alta ($MMA) founder & CEO, unpacks his mission to revolutionise the combat sports fitness industry with technology-enabled training, both in-gym and at home.
Episode 11 | Hydrogen as the Fuel of the Future
Episode 12 | Developing Cancer Cures through the ASX
In Going Public with Will Davidson, the United H2 Limited CEO imparts his expertise launching companies on the ASX and shares his plans to list UHL on the ASX.
In this final episode, Mark sits down with Leslie Chong and Paul Hopper, who have spent over a decade working together to discover promising cancer treatments.
In partnership with Mark Bouris
“My name is Mark Bouris, and I’ve teamed up with Stake, one of Australia’s top investing platforms, to talk about going public.”
To bring Going Public to life, we’ve partnered with none other than ‘the everywhere man of Australian finance’, Mark Bouris.
An Aussie entrepreneur who’s been innovating for decades, Mark made his name by challenging the business landscape with disruptive models that help customers succeed. He brings his wealth of business experience to ask all the right questions to his guests, making each conversation insightful, candid and engaging.